Non-opioid Pain Patch Market was valued US$ 3.30 Mn in 2022 and is expected to reach US$ 4.37 Mn by 2029, at CAGR of 4.1 % during forecast period. The non-opioid pain patch is a treatment for pain relief. The pain patch, once placed on a painful area releases its medicine content through the skin surface and block the pain signal transmission.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report The growth in the occurrence of pain disorders has increased the demand for different approaches for pain management. Furthermore, an increase in costs associated with the treatment, and a growing number of people with chronic, and acute pain are some of the key driving factors for the growth of the market. Also, a rise in the misuse of opioid medication has also increased the R&D to develop non-opioid medication, which will further fuel the market's non-opioid pain patch growth. Furthermore, robust product pipelines of significant market players managing acute and chronic pain, neurological disorders, and other conditions will present the growth opportunities to the non-opioid pain patch market. However, side-effects with continued and excessive use of non-opioid medication such as damage to the liver or kidneys can hinder the non-opioid pain patch market growth. Based on the distribution channel, hospitals hold a significant market share of xx% of the non-opioid pain patch market, on account of frequent patient visits for pain management, mainly by patients suffering from musculoskeletal disorders and other diseases that cause acute and chronic pain. Long-term use of painkillers usually brings about an additional risk of medication-related adverse effects. So, physicians usually prescribe patches as an alternative to oral drugs. By online pharmacies, the sale of drugs and medical devices has observed a surge following the emergence of online pharmacies. Region-wise, in 2018, North America was accounted for the largest revenue share of xx% of the non-opioid pain patch market and anticipated to continue in the forecast period. Increasing incidence of pain and pain-related disorders coupled with the rising opioid epidemic in the U.S. are among the factors driving the market in this region. Also, the Asia Pacific region is witnessing a lucrative growth in the pharmaceutical and medical device industries. The region exhibited the highest CAGR of xx% during the forecast period. The report covers recent development of the market non-opioid pain patch such as Feb 2018, FDA approved lidocaine topical system (ZTlido, Sorrento Therapeutics) 1.8% for the treatment of pain associated with post-herpetic neuralgia (PHA). Approval of this next-generation lidocaine patch marks substantial progress for analgesics because it can deliver pain relief for up to 12 hr, including during exercise.
The objective of the report is to present comprehensive analysis of global market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding global non-opioid pain patch market dynamics, structure by analyzing the market segments, and project the global non-opioid pain patch market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the global non-opioid pain patch market make the report investor’s guide.
Scope of the Global Non-opioid Pain Patch Market: Inquire before buying
Global Non-opioid Pain Patch Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 3.30Bn. Forecast Period 2023 to 2029 CAGR: 4.1% Market Size in 2029: US $ 4.37 Bn. Segments Covered: by Patch Type Capsaicin Patches Lidocaine Patches Diclofenac Patches Ketoprofen Patches Methyl Salicylate Patches Others by Distribution Channel Hospital Pharmacies Online Pharmacies Independent Pharmacies & Drug Stores Non-opioid Pain Patch Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key Players:
1. Pfizer 2. GlaxoSmithKline 3. Johnson & Johnson 4. Novartis AG 5. Mylan N.V. 6. Teva Pharmaceutical Industries 7. Hisamitsu Pharmaceutical 8. TEH SENG Pharmaceutical 9. Teikoku Seiyaku 10.IBSA Institut Biochimque SA 11.Acorda Therapeutics 12.Allergan PLC 13.Endo International 14.Clarion Brands Inc. 15.Sanofi S.A. 16.Sorrento Therapeutics 17.Veridian Healthcare Frequently Asked questions 1. What is the market size of the Global Market in 2022? Ans. The market size Global Market in 2022 was US$ 3.30 Billion. 2. What are the different segments of the Global Non-opioid Pain Patch Market? Ans. The Global Market is divided into Patch Type and Distribution Channel. 3. What is the study period of this market? Ans. The Global Market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global Market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Market? Ans. The Forecast Period of the market is 2023-2029 in the market.
Global Non-opioid Pain Patch Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Non-opioid Pain Patch Market, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Non-opioid Pain Patch Market Analysis and Forecast 6.1. Global Non-opioid Pain Patch Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Non-opioid Pain Patch Market Analysis and Forecast, by Patch Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Non-opioid Pain Patch Market Value Share Analysis, by Patch Type 7.4. Global Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Patch Type 7.5. Global Non-opioid Pain Patch Market Analysis, by Patch Type 7.6. Global Non-opioid Pain Patch Market Attractiveness Analysis, by Patch Type 8. Global Non-opioid Pain Patch Market Analysis and Forecast, by Distribution Channel 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Non-opioid Pain Patch Market Value Share Analysis, by Distribution Channel 8.4. Global Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel 8.5. Global Non-opioid Pain Patch Market Analysis, by Distribution Channel 8.6. Global Non-opioid Pain Patch Market Attractiveness Analysis, by Distribution Channel 9. Global Non-opioid Pain Patch Market Analysis, by Region 9.1. Global Non-opioid Pain Patch Market Value Share Analysis, by Region 9.2. Global Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Region 9.3. Global Non-opioid Pain Patch Market Attractiveness Analysis, by Region 10. North America Non-opioid Pain Patch Market Analysis 10.1. Key Findings 10.2. North America Non-opioid Pain Patch Market Overview 10.3. North America Non-opioid Pain Patch Market Value Share Analysis, by Patch Type 10.4. North America Non-opioid Pain Patch Market Forecast, by Patch Type 10.4.1. Capsaicin Patches 10.4.2. Lidocaine Patches 10.4.3. Diclofenac Patches 10.4.4. Ketoprofen Patches 10.4.5. Methyl Salicylate Patches 10.4.6. Others 10.5. North America Non-opioid Pain Patch Market Value Share Analysis, by Distribution Channel 10.6. North America Non-opioid Pain Patch Market Forecast, by Distribution Channel 10.6.1. Hospital Pharmacies 10.6.2. Online Pharmacies 10.6.3. Independent Pharmacies & Drug Stores 10.7. North America Non-opioid Pain Patch Market Value Share Analysis, by Country 10.8. North America Non-opioid Pain Patch Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Non-opioid Pain Patch Market Analysis, by Country 10.10. U.S. Non-opioid Pain Patch Market Forecast, by Patch Type 10.10.1. Capsaicin Patches 10.10.2. Lidocaine Patches 10.10.3. Diclofenac Patches 10.10.4. Ketoprofen Patches 10.10.5. Methyl Salicylate Patches 10.10.6. Others 10.11. U.S. Non-opioid Pain Patch Market Forecast, by Distribution Channel 10.11.1. Hospital Pharmacies 10.11.2. Online Pharmacies 10.11.3. Independent Pharmacies & Drug Stores 10.12. Canada Non-opioid Pain Patch Market Forecast, by Patch Type 10.12.1. Capsaicin Patches 10.12.2. Lidocaine Patches 10.12.3. Diclofenac Patches 10.12.4. Ketoprofen Patches 10.12.5. Methyl Salicylate Patches 10.12.6. Others 10.13. Canada Non-opioid Pain Patch Market Forecast, by Distribution Channel 10.13.1. Hospital Pharmacies 10.13.2. Online Pharmacies 10.13.3. Independent Pharmacies & Drug Stores 10.14. North America Non-opioid Pain Patch Market Attractiveness Analysis 10.14.1. By Patch Type 10.14.2. By Distribution Channel 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Non-opioid Pain Patch Market Analysis 11.1. Key Findings 11.2. Europe Non-opioid Pain Patch Market Overview 11.3. Europe Non-opioid Pain Patch Market Value Share Analysis, by Patch Type 11.4. Europe Non-opioid Pain Patch Market Forecast, by Patch Type 11.4.1. Capsaicin Patches 11.4.2. Lidocaine Patches 11.4.3. Diclofenac Patches 11.4.4. Ketoprofen Patches 11.4.5. Methyl Salicylate Patches 11.4.6. Others 11.5. Europe Non-opioid Pain Patch Market Value Share Analysis, by Distribution Channel 11.6. Europe Non-opioid Pain Patch Market Forecast, by Distribution Channel 11.6.1. Hospital Pharmacies 11.6.2. Online Pharmacies 11.6.3. Independent Pharmacies & Drug Stores 11.7. Europe Non-opioid Pain Patch Market Value Share Analysis, by Country 11.8. Europe Non-opioid Pain Patch Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Non-opioid Pain Patch Market Analysis, by Country 11.10. Germany Non-opioid Pain Patch Market Forecast, by Patch Type 11.10.1. Capsaicin Patches 11.10.2. Lidocaine Patches 11.10.3. Diclofenac Patches 11.10.4. Ketoprofen Patches 11.10.5. Methyl Salicylate Patches 11.10.6. Others 11.11. Germany Non-opioid Pain Patch Market Forecast, by Distribution Channel 11.11.1. Hospital Pharmacies 11.11.2. Online Pharmacies 11.11.3. Independent Pharmacies & Drug Stores 11.12. U.K. Non-opioid Pain Patch Market Forecast, by Patch Type 11.12.1. Capsaicin Patches 11.12.2. Lidocaine Patches 11.12.3. Diclofenac Patches 11.12.4. Ketoprofen Patches 11.12.5. Methyl Salicylate Patches 11.12.6. Others 11.13. U.K. Non-opioid Pain Patch Market Forecast, by Distribution Channel 11.13.1. Hospital Pharmacies 11.13.2. Online Pharmacies 11.13.3. Independent Pharmacies & Drug Stores 11.14. France Non-opioid Pain Patch Market Forecast, by Patch Type 11.14.1. Capsaicin Patches 11.14.2. Lidocaine Patches 11.14.3. Diclofenac Patches 11.14.4. Ketoprofen Patches 11.14.5. Methyl Salicylate Patches 11.14.6. Others 11.15. France Non-opioid Pain Patch Market Forecast, by Distribution Channel 11.15.1. Hospital Pharmacies 11.15.2. Online Pharmacies 11.15.3. Independent Pharmacies & Drug Stores 11.16. Italy Non-opioid Pain Patch Market Forecast, by Patch Type 11.16.1. Capsaicin Patches 11.16.2. Lidocaine Patches 11.16.3. Diclofenac Patches 11.16.4. Ketoprofen Patches 11.16.5. Methyl Salicylate Patches 11.16.6. Others 11.17. Italy Non-opioid Pain Patch Market Forecast, by Distribution Channel 11.17.1. Hospital Pharmacies 11.17.2. Online Pharmacies 11.17.3. Independent Pharmacies & Drug Stores 11.18. Spain Non-opioid Pain Patch Market Forecast, by Patch Type 11.18.1. Capsaicin Patches 11.18.2. Lidocaine Patches 11.18.3. Diclofenac Patches 11.18.4. Ketoprofen Patches 11.18.5. Methyl Salicylate Patches 11.18.6. Others 11.19. Spain Non-opioid Pain Patch Market Forecast, by Distribution Channel 11.19.1. Hospital Pharmacies 11.19.2. Online Pharmacies 11.19.3. Independent Pharmacies & Drug Stores 11.20. Rest of Europe Non-opioid Pain Patch Market Forecast, by Patch Type 11.20.1. Capsaicin Patches 11.20.2. Lidocaine Patches 11.20.3. Diclofenac Patches 11.20.4. Ketoprofen Patches 11.20.5. Methyl Salicylate Patches 11.20.6. Others 11.21. Rest of Europe Non-opioid Pain Patch Market Forecast, by Distribution Channel 11.21.1. Hospital Pharmacies 11.21.2. Online Pharmacies 11.21.3. Independent Pharmacies & Drug Stores 11.22. Europe Non-opioid Pain Patch Market Attractiveness Analysis 11.22.1. By Patch Type 11.22.2. By Distribution Channel 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Development 12. Asia Pacific Non-opioid Pain Patch Market Analysis 12.1. Key Findings 12.2. Asia Pacific Non-opioid Pain Patch Market Overview 12.3. Asia Pacific Non-opioid Pain Patch Market Value Share Analysis, by Patch Type 12.4. Asia Pacific Non-opioid Pain Patch Market Forecast, by Patch Type 12.4.1. Capsaicin Patches 12.4.2. Lidocaine Patches 12.4.3. Diclofenac Patches 12.4.4. Ketoprofen Patches 12.4.5. Methyl Salicylate Patches 12.4.6. Others 12.5. Asia Pacific Non-opioid Pain Patch Market Value Share Analysis, by Distribution Channel 12.6. Asia Pacific Non-opioid Pain Patch Market Forecast, by Distribution Channel 12.6.1. Hospital Pharmacies 12.6.2. Online Pharmacies 12.6.3. Independent Pharmacies & Drug Stores 12.7. Asia Pacific Non-opioid Pain Patch Market Value Share Analysis, by Country 12.8. Asia Pacific Non-opioid Pain Patch Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Non-opioid Pain Patch Market Analysis, by Country 12.10. China Non-opioid Pain Patch Market Forecast, by Patch Type 12.10.1. Capsaicin Patches 12.10.2. Lidocaine Patches 12.10.3. Diclofenac Patches 12.10.4. Ketoprofen Patches 12.10.5. Methyl Salicylate Patches 12.10.6. Others 12.11. China Non-opioid Pain Patch Market Forecast, by Distribution Channel 12.11.1. Hospital Pharmacies 12.11.2. Online Pharmacies 12.11.3. Independent Pharmacies & Drug Stores 12.12. India Non-opioid Pain Patch Market Forecast, by Patch Type 12.12.1. Capsaicin Patches 12.12.2. Lidocaine Patches 12.12.3. Diclofenac Patches 12.12.4. Ketoprofen Patches 12.12.5. Methyl Salicylate Patches 12.12.6. Others 12.13. India Non-opioid Pain Patch Market Forecast, by Distribution Channel 12.13.1. Hospital Pharmacies 12.13.2. Online Pharmacies 12.13.3. Independent Pharmacies & Drug Stores 12.14. Japan Non-opioid Pain Patch Market Forecast, by Patch Type 12.14.1. Capsaicin Patches 12.14.2. Lidocaine Patches 12.14.3. Diclofenac Patches 12.14.4. Ketoprofen Patches 12.14.5. Methyl Salicylate Patches 12.14.6. Others 12.15. Japan Non-opioid Pain Patch Market Forecast, by Distribution Channel 12.15.1. Hospital Pharmacies 12.15.2. Online Pharmacies 12.15.3. Independent Pharmacies & Drug Stores 12.16. ASEAN Non-opioid Pain Patch Market Forecast, by Patch Type 12.16.1. Capsaicin Patches 12.16.2. Lidocaine Patches 12.16.3. Diclofenac Patches 12.16.4. Ketoprofen Patches 12.16.5. Methyl Salicylate Patches 12.16.6. Others 12.17. ASEAN Non-opioid Pain Patch Market Forecast, by Distribution Channel 12.17.1. Hospital Pharmacies 12.17.2. Online Pharmacies 12.17.3. Independent Pharmacies & Drug Stores 12.18. Rest of Asia Pacific Non-opioid Pain Patch Market Forecast, by Patch Type 12.18.1. Capsaicin Patches 12.18.2. Lidocaine Patches 12.18.3. Diclofenac Patches 12.18.4. Ketoprofen Patches 12.18.5. Methyl Salicylate Patches 12.18.6. Others 12.19. Rest of Asia Pacific Non-opioid Pain Patch Market Forecast, by Distribution Channel 12.19.1. Hospital Pharmacies 12.19.2. Online Pharmacies 12.19.3. Independent Pharmacies & Drug Stores 12.20. Asia Pacific Non-opioid Pain Patch Market Attractiveness Analysis 12.20.1. By Patch Type 12.20.2. By Distribution Channel 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Development 13. Middle East & Africa Non-opioid Pain Patch Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Non-opioid Pain Patch Market Overview 13.3. Middle East & Africa Non-opioid Pain Patch Market Value Share Analysis, by Patch Type 13.4. Middle East & Africa Non-opioid Pain Patch Market Forecast, by Patch Type 13.4.1. Capsaicin Patches 13.4.2. Lidocaine Patches 13.4.3. Diclofenac Patches 13.4.4. Ketoprofen Patches 13.4.5. Methyl Salicylate Patches 13.4.6. Others 13.5. Middle East & Africa Non-opioid Pain Patch Market Value Share Analysis, by Distribution Channel 13.6. Middle East & Africa Non-opioid Pain Patch Market Forecast, by Distribution Channel 13.6.1. Hospital Pharmacies 13.6.2. Online Pharmacies 13.6.3. Independent Pharmacies & Drug Stores 13.7. Middle East & Africa Non-opioid Pain Patch Market Value Share Analysis, by Country 13.8. Middle East & Africa Non-opioid Pain Patch Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Non-opioid Pain Patch Market Analysis, by Country 13.10. GCC Non-opioid Pain Patch Market Forecast, by Patch Type 13.10.1. Capsaicin Patches 13.10.2. Lidocaine Patches 13.10.3. Diclofenac Patches 13.10.4. Ketoprofen Patches 13.10.5. Methyl Salicylate Patches 13.10.6. Others 13.11. GCC Non-opioid Pain Patch Market Forecast, by Distribution Channel 13.11.1. Hospital Pharmacies 13.11.2. Online Pharmacies 13.11.3. Independent Pharmacies & Drug Stores 13.12. South Africa Non-opioid Pain Patch Market Forecast, by Patch Type 13.12.1. Capsaicin Patches 13.12.2. Lidocaine Patches 13.12.3. Diclofenac Patches 13.12.4. Ketoprofen Patches 13.12.5. Methyl Salicylate Patches 13.12.6. Others 13.13. South Africa Non-opioid Pain Patch Market Forecast, by Distribution Channel 13.13.1. Hospital Pharmacies 13.13.2. Online Pharmacies 13.13.3. Independent Pharmacies & Drug Stores 13.14. Rest of Middle East & Africa Non-opioid Pain Patch Market Forecast, by Patch Type 13.14.1. Capsaicin Patches 13.14.2. Lidocaine Patches 13.14.3. Diclofenac Patches 13.14.4. Ketoprofen Patches 13.14.5. Methyl Salicylate Patches 13.14.6. Others 13.15. Rest of Middle East & Africa Non-opioid Pain Patch Market Forecast, by Distribution Channel 13.15.1. Hospital Pharmacies 13.15.2. Online Pharmacies 13.15.3. Independent Pharmacies & Drug Stores 13.16. Middle East & Africa Non-opioid Pain Patch Market Attractiveness Analysis 13.16.1. By Patch Type 13.16.2. By Distribution Channel 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Development 14. South America Non-opioid Pain Patch Market Analysis 14.1. Key Findings 14.2. South America Non-opioid Pain Patch Market Overview 14.3. South America Non-opioid Pain Patch Market Value Share Analysis, by Patch Type 14.4. South America Non-opioid Pain Patch Market Forecast, by Patch Type 14.4.1. Capsaicin Patches 14.4.2. Lidocaine Patches 14.4.3. Diclofenac Patches 14.4.4. Ketoprofen Patches 14.4.5. Methyl Salicylate Patches 14.4.6. Others 14.5. South America Non-opioid Pain Patch Market Value Share Analysis, by Distribution Channel 14.6. South America Non-opioid Pain Patch Market Forecast, by Distribution Channel 14.6.1. Hospital Pharmacies 14.6.2. Online Pharmacies 14.6.3. Independent Pharmacies & Drug Stores 14.7. South America Non-opioid Pain Patch Market Value Share Analysis, by Country 14.8. South America Non-opioid Pain Patch Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Non-opioid Pain Patch Market Analysis, by Country 14.10. Brazil Non-opioid Pain Patch Market Forecast, by Patch Type 14.10.1. Capsaicin Patches 14.10.2. Lidocaine Patches 14.10.3. Diclofenac Patches 14.10.4. Ketoprofen Patches 14.10.5. Methyl Salicylate Patches 14.10.6. Others 14.11. Brazil Non-opioid Pain Patch Market Forecast, by Distribution Channel 14.11.1. Hospital Pharmacies 14.11.2. Online Pharmacies 14.11.3. Independent Pharmacies & Drug Stores 14.12. Mexico Non-opioid Pain Patch Market Forecast, by Patch Type 14.12.1. Capsaicin Patches 14.12.2. Lidocaine Patches 14.12.3. Diclofenac Patches 14.12.4. Ketoprofen Patches 14.12.5. Methyl Salicylate Patches 14.12.6. Others 14.13. Mexico Non-opioid Pain Patch Market Forecast, by Distribution Channel 14.13.1. Hospital Pharmacies 14.13.2. Online Pharmacies 14.13.3. Independent Pharmacies & Drug Stores 14.14. Rest of South America Non-opioid Pain Patch Market Forecast, by Patch Type 14.14.1. Capsaicin Patches 14.14.2. Lidocaine Patches 14.14.3. Diclofenac Patches 14.14.4. Ketoprofen Patches 14.14.5. Methyl Salicylate Patches 14.14.6. Others 14.15. Rest of South America Non-opioid Pain Patch Market Forecast, by Distribution Channel 14.15.1. Hospital Pharmacies 14.15.2. Online Pharmacies 14.15.3. Independent Pharmacies & Drug Stores 14.16. South America Non-opioid Pain Patch Market Attractiveness Analysis 14.16.1. By Patch Type 14.16.2. By Distribution Channel 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Pfizer 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. GlaxoSmithKline 15.3.3. Johnson & Johnson 15.3.4. Novartis AG 15.3.5. Mylan N.V. 15.3.6. Teva Pharmaceutical Industries 15.3.7. Hisamitsu Pharmaceutical 15.3.8. TEH SENG Pharmaceutical 15.3.9. Teikoku Seiyaku 15.3.10. IBSA Institut Biochimque SA 15.3.11. Acorda Therapeutics 15.3.12. Allergan PLC 15.3.13. Endo International 15.3.14. Clarion Brands Inc. 15.3.15. Sanofi S.A. 15.3.16. Sorrento Therapeutics 15.3.17. Veridian Healthcare 16. Primary Key Insights